Turkbey Baris, Choyke Peter L
The Molecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Drive, Building 10, Room B3B69, Bethesda, MD 20892, USA.
Nat Rev Urol. 2014 Nov;11(11):611-2. doi: 10.1038/nrurol.2014.273. Epub 2014 Oct 14.
The prostate is still largely assessed by random biopsy, but developments in prostate MRI and fusion with transrectal ultrasonography (TRUS) have made targeted biopsy of the prostate a reality. MRI/TRUS techniques promise to address the issues of overdiagnosis and underdiagnosis in prostate cancer.
目前前列腺主要仍通过随机活检进行评估,但前列腺磁共振成像(MRI)以及与经直肠超声检查(TRUS)融合技术的发展已使前列腺靶向活检成为现实。MRI/TRUS技术有望解决前列腺癌过度诊断和诊断不足的问题。